XORTX Therapeutics Nominates Three New Directors
XORTX Therapeutics announces that, in connection with its upcoming annual and special meeting of shareholders to be held on March 24, three new director nominees will be proposed for election in the place of three of the current nominees. At the Meeting, Messrs. George Scorsis, Richard Grieve and Mika Grasso will be nominated for election to the Company's board of directors instead of Krysta Davies Foss and Messrs. Raymond Pratt and Paul Van Damme. The Company is currently in negotiations with respect to a significant financing initiative. It is a condition of that financing that the New Nominees be added to the Board in place of the three existing nominees referenced above. In the event that the financing is not completed, the New Nominees will resign from the Board with those vacancies being filled in due course by the Company. The financing is subject to the approval of the TSXV Venture Exchange. George Scorsis is a results-focused executive with over 20 years of leadershipexperience in highly regulated sectors such as pharmaceuticals, and consumer-packaged goods. Exceptional at scaling businesses, optimizingoperations, and managing complex environments, he has led multi-million dollar businesses through transformative growth. Richard Grieve is the COO at Bardel Entertainment, bringing expertise in finance and operational strategies within the media production environment. Their background reflects a strong focus on leadership in media production and financial oversight. Progressing through various roles at Bardel Entertainment, they have demonstrated capabilities in financial management and business affairs. Mika Grasso is an Investment Manager at a family office, where he is responsible for sourcing and evaluating the fund's direct and co-investment efforts. Prior to serving as an Investment Manager, he served as a Finance Associate for Zions Capital Markets from November 2023 until March 2025, Investment Banking Associate at Paulson Investment Company from February 2022 until November 2023, Analyst at Goldman Sachs from August 2021 to February 2022, and as an Analyst on the Real Assets Team at Power Systems Management from May 2020 to August 2021.
